<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03572244</url>
  </required_header>
  <id_info>
    <org_study_id>201507837</org_study_id>
    <nct_id>NCT03572244</nct_id>
  </id_info>
  <brief_title>Laser-Lok Pilot Study</brief_title>
  <official_title>Comparison of Pro-Inflammatory Cytokines and Bone Metabolism Mediators Around Laser-Lok and Machined Transmucosal Abutments: A Pilot, Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Christopher Barwacz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BioHorizons, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A pilot, prospective, randomized clinical trial is proposed. It is primarily aimed at
      assessing the expression of pro-inflammatory cytokine and bone metabolism mediators adjacent
      to Laser-Lok microgrooved (LL) or machined (M) transmucosal healing abutments. The pilot
      study would seek recruitment of 12 subjects requiring replacement of a single, toothbound
      molar or premolar in the maxilla or mandible with an implant-supported restoration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this research study is to compare two different implant abutment designs,
      microgrooved and machined. The implant abutment is the dental prosthetic part that connects
      the implant to the crown. As a part of this study, subjects will have a dental implant
      surgically placed in their jaw bone. The implant will serve as the artificial root. After the
      implant heals, subjects will have the abutment and crown placed on the implant.

      This study will compare levels of inflammation next to the implant abutment. Both implant
      abutment designs are FDA approved but differ in microtexturing. This study will determine if
      these texture differences have any impact on the healing of subjects' jaw bone and gums after
      implant surgery.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 13, 2016</start_date>
  <completion_date type="Anticipated">February 6, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 6, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>6 subjects will be randomized to Laser-Lok placement, and 6 subjects will be randomized to machined healing abutment placement. The assignment will be a 1:1 scheme, with the study coordinator randomly opening pre-assigned envelopes to determine implant.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Paper strip-based PICF sampling</measure>
    <time_frame>8 weeks after implant placement</time_frame>
    <description>Characterize pro-inflammatory and bone-metabolism mediator profiles adjacent to Laser-Lok microgrooved (LL) and machined (M) healing abutments as well as natural teeth after a period of healing (8 weeks) via paper strip-based PICF sampling.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Utilize Periotron 8000 to quantify PICF sample volume</measure>
    <time_frame>8 weeks after implant placement</time_frame>
    <description>Evaluate if functionally-oriented mucosa (analogous to natural teeth) around Laser-Lok microgrooved abutments reduce the volumetric production of PICF, as compared with standard machined abutments, relative to a natural tooth control.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Dental Implants</condition>
  <arm_group>
    <arm_group_label>Laser-Lok</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A Laser-Lok microgrooved implant will be placed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Machine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A machined implant will be placed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laser-Lok</intervention_name>
    <description>A microgrooved abutment will be placed</description>
    <arm_group_label>Laser-Lok</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Machined</intervention_name>
    <description>A machined transmucosal healing abutment will be placed</description>
    <arm_group_label>Machine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or greater

          -  Subjects requiring the replacement of either a tooth-bound molar or premolar in either
             arch that do not require simultaneous implant site development (i.e., bone and/or
             soft-tissue grafting)

          -  Teeth adjacent (mesial and distal) to study site must consist of two stable, natural
             teeth without signs of periodontal attachment loss up to 2.0mm

          -  An opposing dentition with teeth, implants, or fixed prosthesis

          -  Subjects must be willing to forgo use of a provisional appliance (e.g., removable
             interim partial denture (or) &quot;flipper&quot;, essix appliance, etc.) during the active
             portion (from implant placement to 8 week +IP visit) of the study protocol.

          -  Subjects must be willing to follow instructions related to the study procedures

          -  Subjects must have read, understood, and signed the informed consent document

        Exclusion Criteria:

          -  Insufficient interocclusal space for implant placement and/or restoration at study
             site

          -  Insufficient lateral ridge volume for implant placement in a prosthetically-driven
             location

          -  More than 2.0 mm of vertical bone loss at study site as measured from the
             interproximal crestal bone on the adjacent teeth

          -  Untreated rampant caries

          -  Tobacco use free for â‰¤ 6 months

          -  Liver or kidney dysfunction/failure

          -  Active severe infectious diseases that may affect normal healing and/or bone
             metabolism

          -  Uncontrolled diabetes determined as HbA1c value &gt; 7%

          -  Current alcohol or drug abuse

          -  Need for systemic medications (e.g., corticosteroids) that may influence postoperative
             healing and/or osseointegration

          -  History of relevant head/neck cancer and/or radiation of the head/neck within the last
             24 months

          -  Subjects who currently use IV bisphosphonates or have a history of IV bisphosphonate
             use

          -  Subjects with metabolic bone diseases such as severe osteoporosis or Paget's disease
             of bone

          -  Known pregnancy or nursing mothers

          -  Unwilling to forgo use of a provisional appliance (e.g., removable interim partial
             denture (or) &quot;flipper&quot;, essix appliance, etc.) during the active portion (from implant
             placement to 8 week +IP visit) of the study protocol.

          -  Unable or unwilling to return for follow-up visits for a period of 1 year

          -  Unlikely to be able to comply with study procedures according to investigators
             judgement
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chris Barwacz, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Iowa College of Dentistry</affiliation>
  </overall_official>
  <reference>
    <citation>Nevins M, Nevins ML, Camelo M, Boyesen JL, Kim DM. Human histologic evidence of a connective tissue attachment to a dental implant. Int J Periodontics Restorative Dent. 2008 Apr;28(2):111-21.</citation>
    <PMID>18546807</PMID>
  </reference>
  <reference>
    <citation>Pecora GE, Ceccarelli R, Bonelli M, Alexander H, Ricci JL. Clinical evaluation of laser microtexturing for soft tissue and bone attachment to dental implants. Implant Dent. 2009 Feb;18(1):57-66. doi: 10.1097/ID.0b013e31818c5a6d.</citation>
    <PMID>19212238</PMID>
  </reference>
  <reference>
    <citation>Shapoff CA, Lahey B, Wasserlauf PA, Kim DM. Radiographic analysis of crestal bone levels around Laser-Lok collar dental implants. Int J Periodontics Restorative Dent. 2010 Apr;30(2):129-37.</citation>
    <PMID>20228972</PMID>
  </reference>
  <reference>
    <citation>Botos S, Yousef H, Zweig B, Flinton R, Weiner S. The effects of laser microtexturing of the dental implant collar on crestal bone levels and peri-implant health. Int J Oral Maxillofac Implants. 2011 May-Jun;26(3):492-8.</citation>
    <PMID>21691595</PMID>
  </reference>
  <reference>
    <citation>Geurs NC, Vassilopoulos PJ, Reddy MS. Histologic evidence of connective tissue integration on laser microgrooved abutments in humans. Clinical Advances in Periodontics 2011;1:29-33</citation>
  </reference>
  <reference>
    <citation>Nevins M, Camelo M, Nevins ML, Schupbach P, Kim DM. Connective tissue attachment to laser-microgrooved abutments: a human histologic case report. Int J Periodontics Restorative Dent. 2012 Aug;32(4):385-92.</citation>
    <PMID>22577643</PMID>
  </reference>
  <reference>
    <citation>Nevins M, Nevins M, Gobbato L, Lee HJ, Wang CW, Kim DM. Maintaining interimplant crestal bone height via a combined platform-switched, Laser-Lok implant/abutment system: a proof-of-principle canine study. Int J Periodontics Restorative Dent. 2013 May-Jun;33(3):261-7. doi: 10.11607/prd.1773.</citation>
    <PMID>23593619</PMID>
  </reference>
  <reference>
    <citation>Norton MR. Understanding the intimate relationship between biomechanics and optimal clinical performance: application of implant design. Compend Contin Educ Dent. 2002 Sep;23(9 Suppl 2):21-5.</citation>
    <PMID>12790010</PMID>
  </reference>
  <reference>
    <citation>Steigenga JT, al-Shammari KF, Nociti FH, Misch CE, Wang HL. Dental implant design and its relationship to long-term implant success. Implant Dent. 2003;12(4):306-17. Review.</citation>
    <PMID>14752967</PMID>
  </reference>
  <reference>
    <citation>Stanford CM. Biomechanical and functional behavior of implants. Adv Dent Res. 1999 Jun;13:88-92. Review.</citation>
    <PMID>11276753</PMID>
  </reference>
  <reference>
    <citation>Ratner BD. Replacing and renewing: synthetic materials, biomimetics, and tissue engineering in implant dentistry. J Dent Educ. 2001 Dec;65(12):1340-7. Review.</citation>
    <PMID>11780652</PMID>
  </reference>
  <reference>
    <citation>Lowney JJ, Norton LA, Shafer DM, Rossomando EF. Orthodontic forces increase tumor necrosis factor alpha in the human gingival sulcus. Am J Orthod Dentofacial Orthop. 1995 Nov;108(5):519-24.</citation>
    <PMID>7484971</PMID>
  </reference>
  <reference>
    <citation>Fiorellini JP, Nevins ML, Sekler J, Chung A, Oringer RJ. Correlation of peri-implant health and aspartate aminotransferase levels: a cross-sectional clinical study. Int J Oral Maxillofac Implants. 2000 Jul-Aug;15(4):500-4.</citation>
    <PMID>10960982</PMID>
  </reference>
  <reference>
    <citation>Nowzari H, Botero JE, DeGiacomo M, Villacres MC, Rich SK. Microbiology and cytokine levels around healthy dental implants and teeth. Clin Implant Dent Relat Res. 2008 Sep;10(3):166-73. doi: 10.1111/j.1708-8208.2007.00076.x. Epub 2008 Jan 24.</citation>
    <PMID>18218050</PMID>
  </reference>
  <reference>
    <citation>Nowzari H, Phamduong S, Botero JE, Villacres MC, Rich SK. The profile of inflammatory cytokines in gingival crevicular fluid around healthy osseointegrated implants. Clin Implant Dent Relat Res. 2012 Aug;14(4):546-52. doi: 10.1111/j.1708-8208.2010.00299.x. Epub 2010 Jul 17.</citation>
    <PMID>20662860</PMID>
  </reference>
  <reference>
    <citation>Schierano G, Pejrone G, Brusco P, Trombetta A, Martinasso G, Preti G, Canuto RA. TNF-alpha TGF-beta2 and IL-1beta levels in gingival and peri-implant crevicular fluid before and after de novo plaque accumulation. J Clin Periodontol. 2008 Jun;35(6):532-8. doi: 10.1111/j.1600-051X.2008.01224.x. Epub 2008 Apr 1.</citation>
    <PMID>18384390</PMID>
  </reference>
  <reference>
    <citation>Salvi GE, Aglietta M, Eick S, Sculean A, Lang NP, Ramseier CA. Reversibility of experimental peri-implant mucositis compared with experimental gingivitis in humans. Clin Oral Implants Res. 2012 Feb;23(2):182-190. doi: 10.1111/j.1600-0501.2011.02220.x. Epub 2011 Aug 2.</citation>
    <PMID>21806683</PMID>
  </reference>
  <reference>
    <citation>PetkoviÄ‡ AB, MatiÄ‡ SM, StamatoviÄ‡ NV, VojvodiÄ‡ DV, TodoroviÄ‡ TM, LaziÄ‡ ZR, Kozomara RJ. Proinflammatory cytokines (IL-1beta and TNF-alpha) and chemokines (IL-8 and MIP-1alpha) as markers of peri-implant tissue condition. Int J Oral Maxillofac Surg. 2010 May;39(5):478-85. doi: 10.1016/j.ijom.2010.01.014. Epub 2010 Mar 5.</citation>
    <PMID>20207110</PMID>
  </reference>
  <reference>
    <citation>Murata M, Tatsumi J, Kato Y, Suda S, Nunokawa Y, Kobayashi Y, Takeda H, Araki H, Shin K, Okuda K, Miyata T, Yoshie H. Osteocalcin, deoxypyridinoline and interleukin-1beta in peri-implant crevicular fluid of patients with peri-implantitis. Clin Oral Implants Res. 2002 Dec;13(6):637-43.</citation>
    <PMID>12519339</PMID>
  </reference>
  <reference>
    <citation>Severino VO, Napimoga MH, de Lima Pereira SA. Expression of IL-6, IL-10, IL-17 and IL-8 in the peri-implant crevicular fluid of patients with peri-implantitis. Arch Oral Biol. 2011 Aug;56(8):823-8. doi: 10.1016/j.archoralbio.2011.01.006. Epub 2011 Feb 8.</citation>
    <PMID>21306703</PMID>
  </reference>
  <reference>
    <citation>Javed F, Al-Hezaimi K, Salameh Z, Almas K, Romanos GE. Proinflammatory cytokines in the crevicular fluid of patients with peri-implantitis. Cytokine. 2011 Jan;53(1):8-12. doi: 10.1016/j.cyto.2010.08.013. Epub 2010 Sep 25. Review.</citation>
    <PMID>20870421</PMID>
  </reference>
  <reference>
    <citation>Lachmann S, Kimmerle-MÃ¼ller E, Axmann D, Scheideler L, Weber H, Haas R. Associations between peri-implant crevicular fluid volume, concentrations of crevicular inflammatory mediators, and composite IL-1A -889 and IL-1B +3954 genotype. A cross-sectional study on implant recall patients with and without clinical signs of peri-implantitis. Clin Oral Implants Res. 2007 Apr;18(2):212-23.</citation>
    <PMID>17348886</PMID>
  </reference>
  <reference>
    <citation>Andreiotelli M, Koutayas SO, Madianos PN, Strub JR. Relationship between interleukin-1 genotype and peri-implantitis: a literature review. Quintessence Int. 2008 Apr;39(4):289-98. Review.</citation>
    <PMID>19081897</PMID>
  </reference>
  <reference>
    <citation>BoynueÄŸri AD, Yalim M, Nemli SK, ErgÃ¼der BI, GÃ¶kalp P. Effect of different localizations of microgap on clinical parameters and inflammatory cytokines in peri-implant crevicular fluid: a prospective comparative study. Clin Oral Investig. 2012 Apr;16(2):353-61. doi: 10.1007/s00784-010-0497-4. Epub 2011 Jan 7.</citation>
    <PMID>21212999</PMID>
  </reference>
  <reference>
    <citation>Ataoglu H, Alptekin NO, Haliloglu S, Gursel M, Ataoglu T, Serpek B, Durmus E. Interleukin-1beta, tumor necrosis factor-alpha levels and neutrophil elastase activity in peri-implant crevicular fluid. Clin Oral Implants Res. 2002 Oct;13(5):470-6.</citation>
    <PMID>12453123</PMID>
  </reference>
  <reference>
    <citation>Barwacz CA, Brogden KA, Stanford CM, Dawson DV, Recker EN, Blanchette D. Comparison of pro-inflammatory cytokines and bone metabolism mediators around titanium and zirconia dental implant abutments following a minimum of 6 months of clinical function. Clin Oral Implants Res. 2015 Apr;26(4):e35-e41. doi: 10.1111/clr.12326. Epub 2014 Jan 13.</citation>
    <PMID>24417614</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>June 19, 2018</study_first_submitted>
  <study_first_submitted_qc>June 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2018</study_first_posted>
  <last_update_submitted>March 23, 2020</last_update_submitted>
  <last_update_submitted_qc>March 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Christopher Barwacz</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Laser-Lok</keyword>
  <keyword>Crevicular fluid</keyword>
  <keyword>Machined</keyword>
  <keyword>Abutment</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

